Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients
- PMID: 8567191
- DOI: 10.2190/N6C0-DWX2-G4EA-7688
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients
Abstract
Objective: After the advent of selective serotonin reuptake inhibitors on the U.S. market in 1988, American psychiatrists have been faced with more choices of antidepressants for the treatment of depression. The prescribing of SSRIs has been increasing in popularity because they are easily titrated by the physicians and tolerated by patients. However, the SSRI use is frequently associated with female sexual dysfunction. The aim of this study was to describe these SSRI-associated female sexual side effects.
Methods: In a retrospective series, clinic records of 110 female SSRI-treated outpatients were reviewed for loss of or decreased libido, orgasmic disturbances (anorgasmia or delayed orgasm), as well as clinical management patterns to alleviate sexual side effects.
Results: Twenty-one fluoxetine-, nine paroxetine-, and five sertraline-treated cases with female sexual inhibition were identified. The fates of SSRI-associated sexual adverse effects and clinical managements of restoring these side effects were described.
Conclusions: With some limitations in interpreting the data, the findings of this study suggest that SSRI-associated female sexual dysfunction occurs at a higher rate than we previously thought, equal potentials in implicating female sexual side effects among three SSRIs, and the absence or the low incidence of female sexual adverse effects from bupropion, and that these side effects can be managed by waiting for a spontaneous remission, dosage reduction of SSRIs, substitution with bupropion and other antidepressants, or the use of an antidote.
Similar articles
-
[Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients].Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996 Nov-Dec;24(6):311-21. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1996. PMID: 9054202 Clinical Trial. Spanish.
-
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.J Sex Marital Ther. 1997 Fall;23(3):176-94. doi: 10.1080/00926239708403923. J Sex Marital Ther. 1997. PMID: 9292833 Review.
-
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.Clin Pharmacol Ther. 1997 Apr;61(4):476-87. doi: 10.1016/S0009-9236(97)90198-3. Clin Pharmacol Ther. 1997. PMID: 9129565
-
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.Ann Clin Psychiatry. 1997 Dec;9(4):241-5. doi: 10.1023/a:1022356427242. Ann Clin Psychiatry. 1997. PMID: 9511948
-
Management of SSRI-induced sexual dysfunction.Ann Pharmacother. 1998 Nov;32(11):1209-15. doi: 10.1345/aph.17428. Ann Pharmacother. 1998. PMID: 9825088 Review.
Cited by
-
Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.Drug Saf. 1998 Jan;18(1):57-82. doi: 10.2165/00002018-199818010-00005. Drug Saf. 1998. PMID: 9466088 Review.
-
Sex differences in the psychopharmacological treatment of depression.Dialogues Clin Neurosci. 2016 Dec;18(4):447-457. doi: 10.31887/DCNS.2016.18.4/ncutler. Dialogues Clin Neurosci. 2016. PMID: 28179816 Free PMC article. Review.
-
Fluoxetine-induced decrements in sexual responses of female rats and hamsters are reversed by 3α,5α-THP.J Sex Med. 2010 Aug;7(8):2670-80. doi: 10.1111/j.1743-6109.2010.01814.x. Epub 2010 Apr 20. J Sex Med. 2010. PMID: 20412429 Free PMC article.
-
Use of an operant paradigm for the study of antidepressant-induced sexual dysfunction.Behav Pharmacol. 2015 Oct;26(7 Spec No):697-705. doi: 10.1097/FBP.0000000000000177. Behav Pharmacol. 2015. PMID: 26274043 Free PMC article.
-
Plasma Oxytocin Level and Sexual Dysfunction in Depressed Women Treated by Either Fluoxetine or Citalopram: a Pilot Clinical Trial.Iran J Pharm Res. 2018 Winter;17(1):408-414. Iran J Pharm Res. 2018. PMID: 29755571 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical